Coeptis Therapeutics Holdings, Inc. /
Deverra Therapeutics Inc.
Coeptis Therapeutics Holdings, Inc. completes transactions with Deverra Therapeutics Inc.
What happened
Coeptis Therapeutics Holdings, Inc. completed transactions with Deverra Therapeutics Inc. involving licensing and asset purchase agreements for intellectual property related to a stem cell platform.
The platform supports the generation of immune effector cell types, including natural killer cells and monocytes/macrophages. Terms weren't disclosed.
The source
Everything on this page comes from the source below.
Coeptis Therapeutics Holdings, Inc. completes transactions with Deverra Therapeutics Inc.
This document is the source for the companies, stage and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly